1. Home
  2. LOB vs SPRY Comparison

LOB vs SPRY Comparison

Compare LOB & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOB
  • SPRY
  • Stock Information
  • Founded
  • LOB 2008
  • SPRY 2015
  • Country
  • LOB United States
  • SPRY United States
  • Employees
  • LOB N/A
  • SPRY N/A
  • Industry
  • LOB Major Banks
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • LOB Finance
  • SPRY Health Care
  • Exchange
  • LOB Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • LOB 1.3B
  • SPRY 1.2B
  • IPO Year
  • LOB 2015
  • SPRY N/A
  • Fundamental
  • Price
  • LOB $24.22
  • SPRY $14.88
  • Analyst Decision
  • LOB Buy
  • SPRY Strong Buy
  • Analyst Count
  • LOB 4
  • SPRY 4
  • Target Price
  • LOB $44.75
  • SPRY $28.75
  • AVG Volume (30 Days)
  • LOB 491.7K
  • SPRY 2.2M
  • Earning Date
  • LOB 04-23-2025
  • SPRY 05-08-2025
  • Dividend Yield
  • LOB 0.50%
  • SPRY N/A
  • EPS Growth
  • LOB 3.05
  • SPRY N/A
  • EPS
  • LOB 1.69
  • SPRY 0.08
  • Revenue
  • LOB $402,944,000.00
  • SPRY $89,149,000.00
  • Revenue This Year
  • LOB $35.22
  • SPRY $1.49
  • Revenue Next Year
  • LOB $18.70
  • SPRY $141.68
  • P/E Ratio
  • LOB $14.33
  • SPRY $186.00
  • Revenue Growth
  • LOB 3.04
  • SPRY 297063.34
  • 52 Week Low
  • LOB $22.68
  • SPRY $7.55
  • 52 Week High
  • LOB $50.57
  • SPRY $18.51
  • Technical
  • Relative Strength Index (RSI)
  • LOB 38.08
  • SPRY 66.37
  • Support Level
  • LOB $22.68
  • SPRY $11.80
  • Resistance Level
  • LOB $24.36
  • SPRY $15.12
  • Average True Range (ATR)
  • LOB 1.38
  • SPRY 1.04
  • MACD
  • LOB 0.11
  • SPRY 0.20
  • Stochastic Oscillator
  • LOB 33.41
  • SPRY 92.77

About LOB Live Oak Bancshares Inc.

Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: